The Charles M. Vallee Biorepository for Long COVID Science
EMORY & VANDERBILT UNIVERSITY MEDICAL CENTERS
WES ELY, MD, MPH
Critical care pulmonologist, Professor of Medicine, and Co-Director of the Center for Critical Illness, Brain Dysfunction, and Survivorship, Vanderbilt University Medical Center
VINCENT MARCONI, MD
Professor of Medicine and Global Health, Division of Infectious Disease, Emory University School of Medicine
The establishment of the Charles M. Vallee biorepository holds tremendous potential for advancing our understanding of Long COVID and its underlying mechanisms. By collecting and storing high-quality samples, researchers will have a valuable resource at their disposal to conduct a wide range of studies. This will enable investigations into the biological and immunological factors contributing to Long COVID, as well as the identification of potential biomarkers for diagnosis, prognosis, and treatment response.
Furthermore, the biorepository will facilitate collaborative research efforts among scientists from various institutions and disciplines. By providing access to samples and data, researchers worldwide will have the opportunity to contribute to the collective understanding of Long COVID, accelerating progress towards effective interventions and therapies.
The impact of the science resulting from the biorepository extends beyond the realm of academia. Findings from these studies have the potential to inform clinical practice, guiding healthcare providers in the diagnosis, management, and treatment of patients with Long COVID.